# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Rosenblatt analyst Chris Brendler maintains Hut 8 (NASDAQ:HUT) with a Buy and raises the price target from $30 to $65.
Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."
Eric Jackson is long Hut 8 (HUT), citing its pivot from a miner to an undervalued AI infrastructure play with 100x potential.
https://x.com/ericjackson/status/1978169949047713855?s=46&t=dtUiyC3dUs5yGRgT9qYHWg
BTIG analyst Gregory Lewis maintains Hut 8 (NASDAQ:HUT) with a Buy and raises the price target from $33 to $55.
Hut 8's (NYSE: HUT) short interest as a percent of float has fallen 9.05% since its last report. According to exchange repo...